Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR3 | P46089 | 1/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 4/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.47 |
| ▸ | MAPT | P10636 | 2/20 | 0.47 |
| ▸ | HPGD | P15428 | 2/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
| ▸ | ATM | Q13315 | 1/20 | 0.47 |
| ▸ | RXRA | P19793 | 1/20 | 0.42 |
| ▸ | RXRB | P28702 | 1/20 | 0.42 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.40 |
| ▸ | ALKBH5 | Q6P6C2 | 1/20 | 0.40 |
| ▸ | FTO | Q9C0B1 | 1/20 | 0.40 |
| ▸ | KIF11 | P52732 | 1/20 | 0.40 |
| ▸ | PGR | P06401 | 1/20 | 0.40 |
| ▸ | TSPO | P30536 | 1/20 | 0.39 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14649293 | 1.00 | GPR3 (0.50) | GPR3L3MBTL1KDM4EMAPTHPGD | |
| SCHEMBL14133047 | 0.98 | GPR3 (0.48) | GPR3L3MBTL1KDM4EMAPTHPGD | |
| SCHEMBL21031230 | 0.97 | KDM4E (0.49) | GPR3L3MBTL1KDM4EMAPTHPGD | |
| SCHEMBL22906534 | 0.96 | KDM4E (0.47) | GPR3L3MBTL1KDM4EMAPTHPGD | |
| SCHEMBL14649295 | 0.94 | KDM4E (0.50) | GPR3L3MBTL1KDM4EMAPTHPGD | |
| SCHEMBL14649438 | 0.94 | KDM4E (0.46) | GPR3L3MBTL1KDM4EMAPTHPGD | |
| SCHEMBL26049045 | 0.92 | KDM4E (0.44) | GPR3L3MBTL1KDM4EMAPTHPGD | |
| SCHEMBL19101097 | 0.91 | KDM4E (0.56) | GPR3L3MBTL1KDM4EMAPTHPGD | |
| SCHEMBL14649450 | 0.91 | L3MBTL1 (0.54) | GPR3L3MBTL1KDM4EMAPTHPGD | |
| SCHEMBL14649354 | 0.91 | GPR3 (0.41) | GPR3L3MBTL1KDM4EMAPTHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10777754-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2020-09-15 | — | — | US | disclosed |
| EP-2910555-B1 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORP (US) | 2019-03-27 | — | — | EP | disclosed |
| EP-2551932-B1 | Host materials for phosphorescent oleds | UNIVERSAL DISPLAY CORP (US) | 2018-05-23 | — | — | EP | disclosed |
| US-9502656-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2016-11-22 | — | — | US | disclosed |
| US-9502656-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2016-11-22 | — | — | US | disclosed |
| US-9184399-B2 | Asymmetric hosts with triaryl silane side chains | UNIVERSAL DISPLAY CORPORATION (US) | 2015-11-10 | — | — | US | disclosed |
| US-9184399-B2 | Asymmetric hosts with triaryl silane side chains | UNIVERSAL DISPLAY CORPORATION (US) | 2015-11-10 | — | — | US | disclosed |
| US-9142788-B2 | Host materials for OLEDs | UNIVERSAL DISPLAY CORPORATION (US) | 2015-09-22 | — | — | US | disclosed |
| US-9142788-B2 | Host materials for OLEDs | UNIVERSAL DISPLAY CORPORATION (US) | 2015-09-22 | — | — | US | disclosed |
| US-20150243893-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2015-08-27 | — | — | US | disclosed |
| US-20130119353-A1 | TRIPHENYLENE SILANE HOSTS | UNIVERSAL DISPLAY CORPORATION (US) | 2013-05-16 | — | — | US | disclosed |
| US-20130119353-A1 | TRIPHENYLENE SILANE HOSTS | UNIVERSAL DISPLAY CORPORATION (US) | 2013-05-16 | — | — | US | disclosed |
| US-8409729-B2 | Host materials for phosphorescent OLEDs | UNIVERSAL DISPLAY CORPORATION (US) | 2013-04-02 | — | — | US | disclosed |
| US-8409729-B2 | Host materials for phosphorescent OLEDs | UNIVERSAL DISPLAY CORPORATION (US) | 2013-04-02 | — | — | US | disclosed |
| US-20130026909-A1 | HOST MATERIALS FOR PHOSPHORESCENT OLEDS | UNIVERSAL DISPLAY CORPORATION (US) | 2013-01-31 | — | — | US | disclosed |
| US-20130026909-A1 | HOST MATERIALS FOR PHOSPHORESCENT OLEDS | UNIVERSAL DISPLAY CORPORATION (US) | 2013-01-31 | — | — | US | disclosed |
| EP-2551932-A2 | Host materials for phosphorescent oleds | Universal Display Corporation (US) | 2013-01-30 | — | — | EP | disclosed |
| US-20120298966-A1 | Host materials for oled | UNIVERSAL DISPLAY CORPORATION (US) | 2012-11-29 | — | — | US | disclosed |
| US-20120298966-A1 | Host materials for oled | UNIVERSAL DISPLAY CORPORATION (US) | 2012-11-29 | — | — | US | disclosed |
| WO-2012162325-A1 | HOST MATERIALS FOR OLEDS | UNIVERSAL DISPLAY CORPORATION (US) | 2012-11-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120298966-A1 | Host materials for oled | OCIAD2, OCIAD1, OSBP2 | GPR3 655/4885L3MBTL1 1065/4885KDM4E 3086/4885 |
| US-20130119353-A1 | TRIPHENYLENE SILANE HOSTS | OCIAD2, OCIAD1, YAP1 | GPR3 971/4885L3MBTL1 659/4885KDM4E 3627/4885 |
| US-20130026909-A1 | HOST MATERIALS FOR PHOSPHORESCENT OLEDS | OSBP2, OCIAD2, OCIAD1 | GPR3 380/4885L3MBTL1 1959/4885KDM4E 3835/4885 |
| US-10777754-B2 | Organic electroluminescent materials and devices | DBF4, ORC3, NUDC | GPR3 3953/4885L3MBTL1 2225/4885KDM4E 1719/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.